BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24037912)

  • 1. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
    Wu B; Guo D; Guo Y
    Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
    Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
    Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
    Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
    Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
    Liu ZH; Bao ED
    Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
    Lv L; Wang P; Zhou X; Sun B
    Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
    Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.
    Liu L; Wang K; Zhu ZM; Shao JH
    Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies.
    Diakite B; Kassogue Y; Dolo G; Wang J; Neuschler E; Kassogue O; Keita ML; Traore CB; Kamate B; Dembele E; Nadifi S; Murphy RL; Doumbia S; Hou L; Maiga M
    BMC Med Genet; 2020 Oct; 21(1):206. PubMed ID: 33076844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
    Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
    PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
    Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
    BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
    Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
    BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.
    Cai K; Wang Y; Zhao X; Bao X
    Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis.
    Zhou X; Gu Y; Zhang SL
    Asian Pac J Cancer Prev; 2012; 13(10):4909-14. PubMed ID: 23244080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population.
    Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD
    Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
    Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
    World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis.
    Zhang Y; Zhang D; Zhao L; Sun L; Dong Q; Cheng L; Cheng R
    Curr Probl Cancer; 2018 Nov; 42(6):582-592. PubMed ID: 30316510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis.
    Tang W; Zhou X; Nie S; Yang Z; Zhu H; Wu X; Zhao R; Luo Y
    Biomarkers; 2012 Nov; 17(7):597-603. PubMed ID: 22780299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis.
    Jiang DK; Yao L; Ren WH; Wang WZ; Peng B; Yu L
    Med Oncol; 2011 Dec; 28(4):1129-35. PubMed ID: 20552298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.